A citation-based method for searching scientific literature


List of co-cited articles
1 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Mechanisms of ketamine and its metabolites as antidepressants.
Evan M Hess, Lace M Riggs, Michael Michaelides, Todd D Gould. Biochem Pharmacol 2022
14
100


AMPA Receptor Activation-Independent Antidepressant Actions of Ketamine Metabolite (S)-Norketamine.
Chun Yang, Shizuka Kobayashi, Kazuhito Nakao, Chao Dong, Mei Han, Youge Qu, Qian Ren, Ji-Chun Zhang, Min Ma, Hidetoh Toki,[...]. Biol Psychiatry 2018
66
50

Improving Suicide Prevention Through Evidence-Based Strategies: A Systematic Review.
J John Mann, Christina A Michel, Randy P Auerbach. Am J Psychiatry 2021
61
50

An update on ketamine and its two enantiomers as rapid-acting antidepressants.
Kai Zhang, Kenji Hashimoto. Expert Rev Neurother 2019
64
50


Flexible Stoichiometry: Implications for KCNQ2- and KCNQ3-Associated Neurodevelopmental Disorders.
Kristen Springer, Nissi Varghese, Anastasios V Tzingounis. Dev Neurosci 2021
8
50

The Effect of a Single Dose of Intravenous Ketamine on Suicidal Ideation: A Systematic Review and Individual Participant Data Meta-Analysis.
Samuel T Wilkinson, Elizabeth D Ballard, Michael H Bloch, Sanjay J Mathew, James W Murrough, Adriana Feder, Peter Sos, Gang Wang, Carlos A Zarate, Gerard Sanacora. Am J Psychiatry 2018
305
50

Ketamine; history and role in anesthetic pharmacology.
Kazuyoshi Hirota, David G Lambert. Neuropharmacology 2022
1
100

Ketamine and Ketamine Metabolite Pharmacology: Insights into Therapeutic Mechanisms.
Panos Zanos, Ruin Moaddel, Patrick J Morris, Lace M Riggs, Jaclyn N Highland, Polymnia Georgiou, Edna F R Pereira, Edson X Albuquerque, Craig J Thomas, Carlos A Zarate,[...]. Pharmacol Rev 2018
417
50

PHARMACOLOGIC EFFECTS OF CI-581, A NEW DISSOCIATIVE ANESTHETIC, IN MAN.
E F DOMINO, P CHODOFF, G CORSSEN. Clin Pharmacol Ther 1965
619
50

M2 microglia and macrophages drive oligodendrocyte differentiation during CNS remyelination.
Veronique E Miron, Amanda Boyd, Jing-Wei Zhao, Tracy J Yuen, Julia M Ruckh, Jennifer L Shadrach, Peter van Wijngaarden, Amy J Wagers, Anna Williams, Robin J M Franklin,[...]. Nat Neurosci 2013
50

Blood miR-144-3p: a novel diagnostic and therapeutic tool for depression.
Yentl Y van der Zee, Lars M T Eijssen, Philipp Mews, Aarthi Ramakrishnan, Kelvin Alvarez, Casey K Lardner, Hannah M Cates, Deena M Walker, Angélica Torres-Berrío, Caleb J Browne,[...]. Mol Psychiatry 2022
4
50

Antidepressant Potential of (R)-Ketamine in Rodent Models: Comparison with (S)-Ketamine.
Kenichi Fukumoto, Hidetoh Toki, Michihiko Iijima, Takashi Hashihayata, Jun-Ichi Yamaguchi, Kenji Hashimoto, Shigeyuki Chaki. J Pharmacol Exp Ther 2017
142
50

Mechanisms of action of fluvoxamine for COVID-19: a historical review.
Yaeko Hashimoto, Takuji Suzuki, Kenji Hashimoto. Mol Psychiatry 2022
28
50

New antidepressants: New day or false dawn?
Luke A Jelen, Allan H Young. Eur Neuropsychopharmacol 2022
3
50


Mu-opioid receptor and CREB activation are required for nicotine reward.
Carrie L Walters, Jessica N Cleck, Yuo-chen Kuo, Julie A Blendy. Neuron 2005
171
50






Ketamine: A tale of two enantiomers.
Luke A Jelen, Allan H Young, James M Stone. J Psychopharmacol 2021
49
50

Splenic NKG2D confers resilience versus susceptibility in mice after chronic social defeat stress: beneficial effects of (R)-ketamine.
Kai Zhang, Akemi Sakamoto, Lijia Chang, Youge Qu, Siming Wang, Yaoyu Pu, Yunfei Tan, Xingming Wang, Yuko Fujita, Tamaki Ishima,[...]. Eur Arch Psychiatry Clin Neurosci 2021
25
50

Blood-based biomarkers of antidepressant response to ketamine and esketamine: A systematic review and meta-analysis.
Gustavo C Medeiros, Todd D Gould, William L Prueitt, Julie Nanavati, Michael F Grunebaum, Nuri B Farber, Balwinder Singh, Sudhakar Selvaraj, Rodrigo Machado-Vieira, Eric D Achtyes,[...]. Mol Psychiatry 2022
2
50

Comparative pharmacology of the ketamine isomers. Studies in volunteers.
P F White, J Schüttler, A Shafer, D R Stanski, Y Horai, A J Trevor. Br J Anaesth 1985
260
50

Short DNA/RNA heteroduplex oligonucleotide interacting proteins are key regulators of target gene silencing.
Ken Asada, Fumika Sakaue, Tetsuya Nagata, Ji-Chun Zhang, Kie Yoshida-Tanaka, Aya Abe, Makiko Nawa, Kazutaka Nishina, Takanori Yokota. Nucleic Acids Res 2021
4
50



A randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression.
Nancy Diazgranados, Lobna Ibrahim, Nancy E Brutsche, Andrew Newberg, Phillip Kronstein, Sami Khalife, William A Kammerer, Zenaide Quezado, David A Luckenbaugh, Giacomo Salvadore,[...]. Arch Gen Psychiatry 2010
671
50

R (-)-ketamine shows greater potency and longer lasting antidepressant effects than S (+)-ketamine.
Ji-Chun Zhang, Su-Xia Li, Kenji Hashimoto. Pharmacol Biochem Behav 2014
201
50

Antiepileptic therapy approaches in KCNQ2 related epilepsy: A systematic review.
M Kuersten, M Tacke, L Gerstl, H Hoelz, C V Stülpnagel, I Borggraefe. Eur J Med Genet 2020
25
50


Possible role of the gut microbiota-brain axis in the antidepressant effects of (R)-ketamine in a social defeat stress model.
Chun Yang, Youge Qu, Yuko Fujita, Qian Ren, Min Ma, Chao Dong, Kenji Hashimoto. Transl Psychiatry 2017
122
50


Attenuation of Antidepressant Effects of Ketamine by Opioid Receptor Antagonism.
Nolan R Williams, Boris D Heifets, Christine Blasey, Keith Sudheimer, Jaspreet Pannu, Heather Pankow, Jessica Hawkins, Justin Birnbaum, David M Lyons, Carolyn I Rodriguez,[...]. Am J Psychiatry 2018
222
50

Assessment of Ketamine and Its Enantiomers in an Organophosphate-Based Rat Model for Features of Gulf War Illness.
Jackie Zhu, Elisa Hawkins, Kristin Phillips, Laxmikant S Deshpande. Int J Environ Res Public Health 2020
14
50

A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression.
Carlos A Zarate, Jaskaran B Singh, Paul J Carlson, Nancy E Brutsche, Rezvan Ameli, David A Luckenbaugh, Dennis S Charney, Husseini K Manji. Arch Gen Psychiatry 2006
50

Mapping consent practices for outpatient psychiatric use of ketamine.
David S Mathai, Scott M Lee, Victoria Mora, Kelley C O'Donnell, Albert Garcia-Romeu, Eric A Storch. J Affect Disord 2022
1
100

NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses.
Anita E Autry, Megumi Adachi, Elena Nosyreva, Elisa S Na, Maarten F Los, Peng-fei Cheng, Ege T Kavalali, Lisa M Monteggia. Nature 2011
50

N,N-dimethyltryptamine and Amazonian ayahuasca plant medicine.
Edward James, Joachim Keppler, Thomas L Robertshaw, Ben Sessa. Hum Psychopharmacol 2022
8
50

The opioid system in depression.
Luke A Jelen, James M Stone, Allan H Young, Mitul A Mehta. Neurosci Biobehav Rev 2022
3
50

(R)-ketamine as prophylactic and therapeutic drug for neurological disorders: Beyond depression.
Xingming Wang, Jianjun Yang, Kenji Hashimoto. Neurosci Biobehav Rev 2022
4
50

Attenuation of antidepressant and antisuicidal effects of ketamine by opioid receptor antagonism.
Nolan R Williams, Boris D Heifets, Brandon S Bentzley, Christine Blasey, Keith D Sudheimer, Jessica Hawkins, David M Lyons, Alan F Schatzberg. Mol Psychiatry 2019
56
50

Neurobiology of depression.
Eric J Nestler, Michel Barrot, Ralph J DiLeone, Amelia J Eisch, Stephen J Gold, Lisa M Monteggia. Neuron 2002
50

Is (S)-norketamine an alternative antidepressant for esketamine?
Kenji Hashimoto, Chun Yang. Eur Arch Psychiatry Clin Neurosci 2019
24
50

Effect of ketamine, an NMDA receptor inhibitor, in acute and chronic orofacial pain.
Lene Cecilie Mathisen, Per Skjelbred, Lasse A Skoglund, Ivar Øye. Pain 1995
166
50

Antidepressant Effects of (+)-MK-801 and (-)-MK-801 in the Social Defeat Stress Model.
Bangkun Yang, Qian Ren, Min Ma, Qian-Xue Chen, Kenji Hashimoto. Int J Neuropsychopharmacol 2016
34
50



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.